by Sue Robbins | Nov 2, 2020 | Migraine
Treatment with fremanezumab, the fully humanized IgG2?a monoclonal antibody that selectively targets calcitonin gene-related peptide, significantly reduced the number of headache or migraine days experienced before therapy. These findings, from a pooled analysis of...
by Sue Robbins | Oct 20, 2020 | Migraine
A migraine is a neurovascular condition that is described as a debilitating and recurring headache. It is often accompanied by vomiting and some sensory sensitivities. It has been reported that 20% of the people who have migraines turn to prescription medication for...
by Sue Robbins | Oct 18, 2020 | Migraine
Sleep Predicts Migraine Recurrence — Sleep quality may identify patients at risk of developing chronic migraine Sleep quality at a single time point was tied to headaches occurring over the next 6 weeks among people with episodic migraine, a prospective study...
by Sue Robbins | Oct 12, 2020 | Migraine
Protective parenting behavior is associated with significantly greater frequency of adolescent headaches, according to study results published in Headache. Previous studies have shown that adolescent pain severity and pain-related disability are greater when parents...
by Sue Robbins | Oct 5, 2020 | Migraine
A migraine headache is caused by changes in your nervous system. Migraines may progress through four stages: prodrome, aura, attack and postdrome. Not everyone experiences all the stages. Forty to 60% of people with migraines experience a prodrome phase...
by Sue Robbins | Aug 18, 2020 | Migraine
When Jennifer Latson began having migraines at 12, she wasn’t sure exactly what was going on. She just knew she felt terrible. “I would be out sick for a day or two each month,” she said. “It was intense pain, and it made me puke constantly.” Her parents...
